Germitec funding news – Bordeaux-based MedTech Startup Germitec Secures €28.8 Million Funding

‍The round was led by prominent European investment group Eurazeo (€35.5 billion AUM) through its Nov Santé Actions Non Cotées fund, a dedicated platform supporting healthcare companies and innovation. Existing shareholders also participated in the round, demonstrating their confidence in Germitec’s vision and growth trajectory.

Combined with prior funding from the European Investment Bank in20231, this financing positions Germitec for sustained growth over the next two years, with profitability on the horizon.

It’s flagship product line offers healthcare facilities fast, effective, and chemical-free solutions to prevent Healthcare-Associated Infections and improve the standard of care.

Read also - Pixel Photonics funding news – Munster-based DeepTech Startup Pixel Photonics Secures €1 Million in Funding

With global demand for infection prevention on the rise, Germitec’s solutions are well-positioned to address critical needs everywhere ultrasounds are performed: Fertility (IVF2), gynecology, cardiology and ENT3 among other specialties. Thanks to the groundbreaking UV-C technology and its availability in 40 countries, 2.2 million patients are protected across the world every year.

‍With an FDA De Novo granted4 in August 20245and a market opportunity of 60,000 units in the U.S., it is poised to quickly capture market share and double its revenue every year.

Vincent Gardès,Chief Executive Officer of Germitec said , “We are thrilled to welcome Eurazeo as a strategic investor and are equally grateful for the continued support from our existing shareholders, This funding marks a significant milestone for Germitec as we expand our footprint in the U.S. and maintain our commitment to developing cutting-edge disinfection solutions that enhance patient safety and operational efficiency.”

Arnaud Vincent, Managing Director – Healthcare, Eurazeo said, “One of Eurazeo’s key pillars is to invest in major public health challenges. We are therefore extremely proud to support Germitec with its UV-C High-Level Disinfection solutions for ultrasound probes, and its mission to revolutionize infection prevention, Germitec’s innovative UV-C technology aligns with our commitment to foster transformative healthcare solutions that improve patient outcomes and system sustainability.”

The proceeds from this financing round will be allocated to scaling U.S.operations, accelerating commercial adoption and investing in research and development to expand it’s product portfolio. The company’s efforts aim to set new standards for disinfection efficiency and safety in the healthcare industry.

About Germitec

Germitec is a MedTech company dedicated to designing and manufacturing advanced UV-C disinfection solutions for healthcare environments. Its innovative products aim to reduce healthcare-associated infections while streamlining workflow and ensuring safety. It is committed to delivering reliable, eco-friendly, and effective solutions that meet the highest standards of care.